Joseph Schlessinger PhD, MSc
William H. Prusoff Professor of Pharmacology; Chair, Pharmacology; Director, Cancer Biology Institute
Departments & Organizations
Biological and Biomedical Sciences (BBS): Molecular Cell Biology, Genetics and Development | Biochemistry, Biophysics and Structural Biology: Cell Cycle and Signal Transduction; Drug Design, Discovery and Mechanism; Membrane Biology and Motion
Pharmacology: Schlessinger Lab: Investigator
Diabetes Endocrinology Research Center
Center for X-Linked Hypophosphatemia, Yale
Growth factor receptors; Intracellular signaling pathways;protein kinases; phosphorylation; SH2, SH3 and other protein modules involved in signal transduction; drug discovery more...
- B.S., Hebrew University of Jerusalem, 1968
- M.Sc., Hebrew University of Jerusalem, 1969
- Ph.D., Weizmann Institute of Science, Isarel, 1974
- M.A. Lemmon and J. Schlessinger. Cell signaling by receptor tyrosine kinases. Cell 141, 1117-1134 (2010).
- J.H. Bae, T.J. Boggon, F. Tomé, V. Mandiyan, I. Lax, and J. Schlessinger. An asymmetric receptor contact is required for tyrosine autophosphorylation of fibroblast growth factor receptor in living cells. Proc. Natl. Acad. Sci. USA 107, 2866-2871 (2010).
- J.H. Bae, E.D. Lew, S. Yuzawa, F. Tome, I. Lax, and J. Schlessinger. The selectivity of receptor tyrosine kinase signaling is controlled by a secondary SH2 domain binding site. Cell 138, 514-524 (2009).